Karyopharm Theraps Company Profile
What is the competitive landscape for KARYOPHARM THERAPS
KARYOPHARM THERAPS has one approved drug.
There are eleven US patents protecting KARYOPHARM THERAPS drugs.
Drugs and US Patents for Karyopharm Theraps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | No | 9,714,226 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-002 | Apr 15, 2021 | RX | Yes | No | 11,034,660 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-006 | Oct 20, 2025 | RX | Yes | No | 12,291,508 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Karyopharm Theraps Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | 201311666 | ⤷ Start Trial |
| New Zealand | 621520 | ⤷ Start Trial |
| China | 110372672 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Karyopharm Theraps Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2736887 | 2021033 | Norway | ⤷ Start Trial | PRODUCT NAME: SELINEKSOR ELLER ET FARMASOEYTISK AKSEPTABELT SALT DERAV; REG. NO/DATE: EU/1/21/1537 20210408 |
| 2736887 | 132021000000143 | Italy | ⤷ Start Trial | PRODUCT NAME: SELIXENOR O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE(NEXPOVIO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/21/1537, 20210329 |
| 2736887 | 202140024 | Slovenia | ⤷ Start Trial | PRODUCT NAME: SELINEXOR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/21/1537/001-004; DATE OF NATIONAL AUTHORISATION: 20210326; AUTHORITY FOR NATIONAL AUTHORISATION: EU |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.

